138 related articles for article (PubMed ID: 23835755)
21. Evaluation of brimonidine-timolol fixed combination in patients of primary open-angle glaucoma.
Joshi SR; Akat PB; Ramanand JB; Ramanand SJ; Karande VB; Jain SS
Indian J Ophthalmol; 2013 Dec; 61(12):765-7. PubMed ID: 24008808
[TBL] [Abstract][Full Text] [Related]
22. Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension.
Schuman JS
Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S27-37. PubMed ID: 8970247
[TBL] [Abstract][Full Text] [Related]
23. Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.
Hommer A; Kapik B; Shams N;
Br J Ophthalmol; 2003 May; 87(5):592-8. PubMed ID: 12714402
[TBL] [Abstract][Full Text] [Related]
24. Effects of brimonidine timolol fixed combination therapy on anterior ocular segment configuration.
Kim JM; Park KH; Kim CY; Kim HK; Kim TW; Kim MS
Jpn J Ophthalmol; 2011 Jul; 55(4):356-361. PubMed ID: 21681417
[TBL] [Abstract][Full Text] [Related]
25. Efficacy, safety, and current applications of brimonidine.
Fudemberg SJ; Batiste C; Katz LJ
Expert Opin Drug Saf; 2008 Nov; 7(6):795-9. PubMed ID: 18983225
[TBL] [Abstract][Full Text] [Related]
26. Anterior uveitis as a side effect of topical brimonidine.
Byles DB; Frith P; Salmon JF
Am J Ophthalmol; 2000 Sep; 130(3):287-91. PubMed ID: 11020406
[TBL] [Abstract][Full Text] [Related]
27. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group.
Schuman JS; Horwitz B; Choplin NT; David R; Albracht D; Chen K
Arch Ophthalmol; 1997 Jul; 115(7):847-52. PubMed ID: 9230823
[TBL] [Abstract][Full Text] [Related]
28. Brimonidine/Timolol: a viewpoint by Richard Fiscella.
Fiscella R
Drugs Aging; 2006; 23(9):762-3. PubMed ID: 17020400
[No Abstract] [Full Text] [Related]
29. Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components.
Konstas AG; Katsimpris IE; Kaltsos K; Georgiadou I; Kordelou A; Nelson LA; Stewart WC
Eye (Lond); 2008 Nov; 22(11):1391-7. PubMed ID: 17571086
[TBL] [Abstract][Full Text] [Related]
30. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
Nguyen QH; Earl M
J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261
[TBL] [Abstract][Full Text] [Related]
31. Brimonidine/Timolol: a viewpoint by Francisco J. Goñi.
Goñi FJ
Drugs Aging; 2006; 23(9):762-3. PubMed ID: 17020402
[No Abstract] [Full Text] [Related]
32. Comparison of the effects of brimonidine 0.2% and timolol 0.5% on retinal nerve fiber layer thickness in ocular hypertensive patients: a prospective, unmasked study.
Tsai JC; Chang HW
J Ocul Pharmacol Ther; 2005 Dec; 21(6):475-82. PubMed ID: 16386089
[TBL] [Abstract][Full Text] [Related]
33. Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.
Konstas AG; Stewart WC; Topouzis F; Tersis I; Holmes KT; Stangos NT
Am J Ophthalmol; 2001 Jun; 131(6):729-33. PubMed ID: 11384568
[TBL] [Abstract][Full Text] [Related]
34. Multicenter, Randomized, Investigator-Masked Study Comparing Brimonidine Tartrate 0.1% and Timolol Maleate 0.5% as Adjunctive Therapies to Prostaglandin Analogues in Normal-Tension Glaucoma.
Mizoue S; Nitta K; Shirakashi M; Nitta A; Yamabayashi S; Kimura T; Ueda T; Takeda R; Matsumoto S; Yoshikawa K
Adv Ther; 2017 Jun; 34(6):1438-1448. PubMed ID: 28508306
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of the latanoprost/timolol maleate fixed combination vs concomitant brimonidine and latanoprost therapy.
Stewart WC; Stewart JA; Day DG; Sharpe ED; Jenkins JN
Eye (Lond); 2004 Oct; 18(10):990-5. PubMed ID: 15037890
[TBL] [Abstract][Full Text] [Related]
36. Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Belfort R; Paula JS; Lopes Silva MJ; Della Paolera M; Kim T; Chen MY; Goodkin ML
Clin Ther; 2020 Feb; 42(2):263-275. PubMed ID: 32089329
[TBL] [Abstract][Full Text] [Related]
37. Comparison of brimonidine/latanoprost and timolol/dorzolamide: two randomized, double-masked, parallel clinical trials.
Zabriskie N; Netland PA;
Adv Ther; 2003; 20(2):92-100. PubMed ID: 12836809
[TBL] [Abstract][Full Text] [Related]
38. Reduced ocular allergy with fixed-combination 0.2% brimonidine-0.5% timolol.
Alvarado JA
Arch Ophthalmol; 2007 May; 125(5):717; author reply 717-8. PubMed ID: 17502523
[No Abstract] [Full Text] [Related]
39. Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma.
Cho SW; Kim JM; Park KH; Choi CY
Jpn J Ophthalmol; 2010 Sep; 54(5):407-13. PubMed ID: 21052902
[TBL] [Abstract][Full Text] [Related]
40. Systemic beta-blocker therapy and brimonidine and timolol.
Coulibaly R
Ophthalmology; 2001 Aug; 108(8):1368. PubMed ID: 11470677
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
